Archive · 5 Aug 2025
Swiss Stocks Drop on US Tariffs, Pharma Price Pressure
The Swiss stock market went down because the US put taxes on Swiss goods.
These taxes are causing worry.
The US is also asking drug companies to sell their medicine for less.
Switzerland exports a lot of products, like medicine and luxury items, to the US.
Because of these new taxes, Switzerland is trying to make a better trade deal with the US.
Drug companies are worried that the taxes will hurt them.
Swiss stocks fell on Monday due to US tariffs and pressure on drug prices.
The Swiss Market Index dropped as much as 1.9% but recovered slightly.
Drugmakers Novartis and Roche, major index components, saw declines.
The Swiss franc weakened against the euro following the tariff announcement.
Switzerland is one of the US's largest trade partners, with significant exports.
- Who
- Swiss market, US government, Swiss drugmakers.
- What
- Swiss stocks declined due to US tariffs and pressure on drug prices.
- When
- Market reopening on Monday after a holiday.
- Where
- Switzerland and the US.
- Why
- Due to concerns about US tariffs and potential impacts on Swiss pharmaceutical exports.
US
Switzerland
Tariffs
US
Tariffs are used to resolve trade balance and drive negotiations.
Switzerland
The Swiss economy and pharmaceuticals are at risk from tariffs
- Swiss Market Index Drop
- As much as 1.9%
- Swiss Franc Change
- Fell for a second day against the euro
- Swiss Exports to US
- Over $60 billion (last year)
- Bilateral goods trade surplus
- $38.5 billion
- Key Exports to US
- Medical devices, pharmaceuticals
Sources
Switzerland Eyes 'More Attractive' Offer For Donald Trump After Being Slapped With 39% Tariffs
Tariff Shockwaves
Mexico might be the shortcut exporters need to bypass US tariffs
Swiss Gold Trading Takes Spotlight in Trade Talks With Trump